EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson’s Disease

Chunyu Li, Yanbing Hou, Ruwei Ou, Qianqian Wei, Lingyu Zhang, Kuncheng Liu, Junyu Lin, Xueping Chen, Wei Song, Bi Zhao, Ying Wu, Huifang Shang iD

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2024

DOI: 10.1093/gerona/glae155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2024. Verfasst von Chunyu Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurodegenerative Disorders, Department of Neurology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan Un…. Hauptthemen laut MEDLINE: Parkinson Disease, Cognitive Dysfunction, Genome-Wide Association Study, Dipeptidyl-Peptidases and Tripeptidyl-Peptidases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Sichuan Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive decline is among the most common non-motor symptoms in Parkinson’s disease (PD), while its physiological mechanisms remain poorly understood. Genetic factors constituted a fundamental determinant in the heterogeneity of cognitive decline among PD patients. However, the underlying genetic background was still less studied.

Methods

To explore the genetic determinants contributing to cognitive decline in PD, we performed genome-wide survival analysis using a Cox proportional hazards model in a longitudinal cohort of 450 Chinese patients with PD, and further explored the functional effect of the target variant. Additionally, we built a clinical-genetic model by incorporating clinical characteristics and polygenic risk score (PRS) to predict cognitive decline in PD.

Results

The cohort was followed up for an average of 5.25 (SE = 2.46) years, with 95 incidents of cognitive impairment. We identified significant association between locus rs75819919 (DPP6) and accelerated cognitive decline (p = 8.63E-09, beta = 1.74, SE = 0.30). Dual-luciferase reporter assay suggested this locus might be involved in the regulation of DPP6 expression. Using data set from the UK Biobank, we identified rs75819919 was associated with cognitive performance in the general population. Incorporation of PRS increased the model’s predictability, achieving an average AUC of 75.6% through fivefold cross-validation in 1 000 iterations.

Conclusions

These findings improve the current understanding of the genetic etiology of cognitive impairment in PD, and provide a novel target DPP6 to explore therapeutic options. Our results also demonstrate the potential to develop clinical-genetic model to identify patients susceptible to cognitive impairment and thus provide personalized clinical guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseCognitive DysfunctionGenome-Wide Association StudyDipeptidyl-Peptidases and Tripeptidyl-PeptidasesHumansMaleFemaleAgedGenetic Predisposition to DiseaseMiddle AgedRisk FactorsPolymorphism, Single NucleotideLongitudinal StudiesProportional Hazards ModelsChinaNerve Tissue ProteinsPotassium Channels

Stichwörter der Autor:innen

DPP6Cognitive declineGenetic modifiersParkinson’s diseaseProgression

Substanzen

DPP6 protein, humanDipeptidyl-Peptidases and Tripeptidyl-PeptidasesNerve Tissue ProteinsPotassium Channels

Autor:innen und Institutionen

  • Laboratory of Neurodegenerative Disorders, Department of Neurology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Huifang Shang

Förderung

  • National Key Research and Development Program of China
  • Sichuan Science and Technology

Zitieren

APA

Li, C., Hou, Y., Ou, R., Wei, Q., Zhang, L., Liu, K., Lin, J., Chen, X., Song, W., Zhao, B., Wu, Y., & Shang, H. (2024). GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson’s Disease. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glae155

Vancouver

Li C, Hou Y, Ou R, Wei Q, Zhang L, Liu K, et al. GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson’s Disease. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2024. doi:10.1093/gerona/glae155

BibTeX
@article{Li2024,
  author = {Li, Chunyu and Hou, Yanbing and Ou, Ruwei and Wei, Qianqian and Zhang, Lingyu and Liu, Kuncheng and Lin, Junyu and Chen, Xueping and Song, Wei and Zhao, Bi and Wu, Ying and Shang, Huifang},
  title = {GWAS Identifies DPP6 as Risk Gene of Cognitive Decline in Parkinson’s Disease},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2024},
  doi = {10.1093/gerona/glae155}
}
Kostenlos starten →